Physician profile
Mark Strassburg
NPI 1588674659
$1,767.07
in general payments reported to CMS, 2019-2025
16 companies · $66.22 in 2025
The $66.22 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $11.54 · 2021: $142 · 2022: $96.53 · 2023: $186 · 2024: $1,162 · 2025: $66.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,009.01 | 2022-2024 | Qelbree, Qelbree |
| Corium, LLC | $182.51 | 2022-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $149.50 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $77.18 | 2019-2022 | |
| Pfizer INC. | $66.47 | 2023-2025 | |
| Genentech USA, INC. | $64.33 | 2024 | Xolair |
| Sanofi Pasteur INC. | $40.76 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $34.56 | 2024-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ultragenyx Pharmaceutical INC. | $27.98 | 2023 | |
| Sanofi-Aventis U.S. LLC | $20.44 | 2024 | |
| Tris Pharma INC | $20.12 | 2021 | |
| Mirum Pharmaceuticals, INC. | $19.67 | 2024 | Cholbam |
| Neos Therapeutics, LP | $15.92 | 2019 | |
| Glaxosmithkline, LLC. | $13.81 | 2022 | |
| Collegium Pharmaceutical, INC. | $13.70 | 2025 | Jornay Pm |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Strassburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.